Cerebral Therapeutics

Cerebral Therapeutics announces enrolment of first patient in phase 2b trial in epilepsy
Pharmaceutical Business Review
Wed, 11/18/20 - 11:59 am
Cerebral Therapeutics
clinical trials
CT-010
epilepsy